Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

Factors contributing to hematopoietic recovery following chimeric antigen receptor (CAR) T-cell therapy have not been well studied. In an analysis of 83 patients with hematologic malignancies treated with CAR T-cell therapy, we describe patterns of hematopoietic recovery and evaluate potentially ass...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Main Authors: Jain, Tania, Knezevic, Andrea, Pennisi, Martina, Chen, Yunxin, Ruiz, Josel D., Purdon, Terence J., Devlin, Sean M., Smith, Melody, Shah, Gunjan L., Halton, Elizabeth, Diamonte, Claudia, Scordo, Michael, Sauter, Craig S., Mead, Elena, Santomasso, Bianca D., Palomba, M. Lia, Batlevi, Connie W., Maloy, Molly A., Giralt, Sergio, Smith, Eric, Brentjens, Renier, Park, Jae H., Perales, Miguel-Angel, Mailankody, Sham
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2020
Assuntos:
Immunobiology and Immunotherapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422135/
https://ncbi.nlm.nih.gov/pubmed/32780846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002509
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares